The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's
Total Page：16
File Type：pdf, Size：1020Kb
Molecular Neurobiology (2019) 56:5436–5455 https://doi.org/10.1007/s12035-018-1448-3 The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders Kinga Czubowicz1 & Henryk Jęśko2 & Przemysław Wencel1 & Walter J. Lukiw3 & Robert P. Strosznajder1 Received: 2 August 2018 /Accepted: 6 December 2018 /Published online: 5 January 2019 # The Author(s) 2019 Abstract Bioactive sphingolipids—ceramide, sphingosine, and their respective 1-phosphates (C1P and S1P)—are signaling molecules serving as intracellular second messengers. Moreover, S1P acts through G protein-coupled receptors in the plasma membrane. Accumulating evidence points to sphingolipids' engagement in brain aging and in neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s diseases and amyotrophic lateral sclerosis. Metabolic alterations observed in the course of neurodegeneration favor ceramide-dependent pro-apoptotic signaling, while the levels of the neuroprotective S1P are reduced. These trends are observed early in the diseases’ development, suggesting causal relationship. Mechanistic evidence has shown links between altered ceramide/S1P rheostat and the production, secretion, and aggregation of amyloid β/α-synuclein as well as signaling pathways of critical importance for the pathomechanism of protein conformation diseases. Sphingolipids influence multiple aspects of Akt/protein kinase B signaling, a pathway that regulates metabolism, stress response, and Bcl-2 family proteins. The cross-talk between sphingolipids and transcription factors including NF-κB, FOXOs, and AP-1 may be also important for immune regulation and cell survival/death. Sphingolipids regulate exosomes and other secretion mechanisms that can contribute to either the spread of neurotoxic proteins between brain cells, or their clearance. Recent discoveries also suggest the importance of intracellular and exosomal pools of small regulatory RNAs in the creation of disturbed signaling environment in the diseased brain. The identified interactions of bioactive sphingolipids urge for their evaluation as potential therapeutic targets. Moreover, the early disturbances in sphingolipid metabolism may deliver easily accessible biomarkers of neurodegen- erative disorders. Keywords Alzheimer’sdisease . Ceramide . Huntington’sdisease . microRNA . Parkinson’sdisease . Sphingosine-1-phosphate Introduction the development of devastating disorders. Two of the most widespread neurodegenerative diseases are Alzheimer’s(AD) Aging, which itself influences the central nervous system (CNS) and Parkinson’s (PD). Dementia affects estimated 47 million in a relatively subtle manner, creates vulnerable background for people worldwide [1], placing enormous burden on the affected individuals, their families, societies, and healthcare systems. AD is the most common neurodegenerative disorder, responsible for Kinga Czubowicz and Henryk Jęśko contributed equally to this work. up to 70% of dementia cases [1]. This disease is characterized by the presence of aggregates of pathologically misfolded proteins, * Robert P. Strosznajder including the extracellular senile plaques built mainly of amy- [email protected] loid β (Aβ), a product of proteolytic cleavage of the transmem- β β β γ 1 Laboratory of Preclinical Research and Environmental Agents, brane A precursor protein (A PP) by -and -secretase [2]. Department of Neurosurgery, M. Mossakowski Medical Research Neurons in AD also display cytoskeletal abnormalities that are Centre, Polish Academy of Sciences, 5 Pawinskiego St., linked to hyperphosphorylation and aggregation of the PL-02106 Warsaw, Poland microtubule-associated tau protein into intracellular neurofibril- 2 Department of Cellular Signalling, Mossakowski Medical Research lary tangles [3]. Centre, Polish Academy of Sciences, 5 Pawinskiego St., Parkinson’s disease is the most frequently occurring move- PL-02106 Warsaw, Poland ment disease and the second most widespread neurodegener- 3 LSU Neuroscience Center and Departments of Neurology and ative disorder after AD [4]. It is estimated that PD affects up to Ophthalmology, Louisiana State University School of Medicine, New Orleans, LA 70112, USA 1% of people over the age of 60 and up to ca. 4% over 85 [5]. Mol Neurobiol (2019) 56:5436–5455 5437 PD is characterized by subcortical neurodegeneration, includ- pathway. Sphingosine kinases (SPHK1, SPHK2) phosphorylate ing the characteristic loss of dopaminergic phenotype neurons sphingosine into S1P in a highly regulated fashion in various in substantia nigra pars compacta, loss of dopaminergic stria- cellular compartments; dephosphorylation is carried out by S1P tum innervation, and histopathological aberrations in the form phosphatases (SGPP1 and SGPP2), while S1P can be also hy- of α-synuclein (ASN)-containing intracellular Lewy bodies drolyzed irreversibly into ethanolamine phosphate and (LB)/Lewy neurites (LN) [4]. Disturbances in other neuro- hexadecenal by S1P lyase (SGPL) [9]. Activity of the enzyme transmitter systems (serotoninergic, noradrenergic, and cho- glucocerebrosidase (GBA) can be another ceramide source [30] linergic) are increasingly being recognized along non-motor with significant links to Parkinson’sdisease(seePt.'Theroleof symptoms, which—in later stages—may include dementia bioactive sphingolipids in Parkinson’s disease'). [6]. Like AD, Parkinsonian neurodegeneration progresses in a stealthy manner, and when clear symptoms appear the do- S1P and Ceramide in Neuronal Survival and Death paminergic neuron population is already decimated [4]. Signaling Bioactive Sphingolipids Biosynthesis Bioactive sphingolipids employ several mechanisms to exert their influence on intra- and extracellular signaling pathways. Once merely considered structural compounds, bioactive Plasma membrane is one of main cellular regions of SPHK sphingolipids are increasingly implicated as signaling mole- activation; S1P and probably C1P can bind cell surface receptors cules in the brain, and play important roles in aging, neurode- [31, 32]. S1P receptors (S1PR1 to S1PR5) belong to the Edg generative disorders, and the accompanying immune deregula- family and bind G ,G,G , and Rho proteins [31]. While tion [7]. Ceramide, ceramide-1-phosphate (C1P), sphingosine, q i 12/13 data on the postulated C1P receptor is scarce, all S1PR1 to -5 and sphingosine-1-phosphate (S1P) are the best described bio- bind G ,S1PR2and-3bindG and all but S1PR1 signal through active sphingolipids regulating stress resistance, proliferation, i q G (Fig. 1). Through either S1PR-binding G proteins or differentiation, and mature phenotypes of nervous system cells 12/13 through more direct interactions with intracellular enzymes, [8, 9]. Sphingolipids have multiple ancillary roles in the regu- sphingolipids also modulate signaling events such as cAMP lation of cell growth, death, senescence, adhesion, migration, (cyclic adenosine monophosphate), MAPK (mitogen-activated inflammation, angiogenesis, and intracellular trafficking in the protein kinase), PKC (protein kinase C), PLD (phospholipase CNS [10, 11]. The sphingolipid rheostat model ascribed these D), and PI3 kinase–Akt–PKB (protein kinase B) [35, 36]. The compounds clearly opposite roles in cellular survival signaling: PI3K–Akt pathway is a crucial integrator of metabolic and stress ceramide as a cell death activator, while C1P and S1P promoted signals engaged in a plethora of physiological and pathological survival. The fact that single phosphorylation reaction turns processes ranging from energy metabolism through aging to ceramide and sphingosine into their antagonistic counterparts age-related diseases [8]. Sphingolipids are also structural com- stresses the significance of the precise, successful control of ponents of lipid bilayers. Changes in their local concentrations sphingolipid metabolism enzymes [8, 12]. Although the pro- modify membrane properties further modulating signaling versus anti-survival roles have blurred somewhat in recent years events that take part in these membranes. [13], the critical roles of sphingolipid signaling in nervous sys- tem function have been confirmed by effects of mutations in CerK C1P C1PR? C1PP their biosynthesis and receptor genes [14–24]. The importance Cer PKC, CerS Ceramidase 2+ of bioactive sphingolipids is also stressed by the accumulating S1PR2, S1PR3 Gq PLC, Ca cNOS Sph evidence about their involvement in aging and neurodegenera- SphK FOXOs, SGPP PI3K, Akt – GSK-3β, tive disorders [8, 25 29]. S1P S1PR1-S1PR5 Gi Therateofceramidebiosynthesis is controlled by the first step ERK Bax, Bad of the pathway’s de novo branch, which is catalyzed by serine S1PR2-S1PR5 G12/13 Rho NF-κB palmitoyltransferase (SPT). SPT product dihydrosphingosine is then metabolized by ceramide synthase (CERS) to Fig. 1 Signaling pathways triggered by the cell surface receptors for dihydroceramide, which is subsequently converted by S1P (S1PRs) and C1P (C1PR). S1P through its G protein-binding dihydroceramide desaturase (DES or DEGS) to ceramide. receptors modulates pathways known for their engagement in the Ceramide may be metabolized into sphingomyelin by regulation of cellular metabolism oxidative/nitrosative stress and death/ survival. The depicted examples of S1PR-activated signaling pathways sphingomyelin synthase (SMS, or SGMS); the reverse reaction are far from exhausting the spectrum of observed interactions (e.g., (the sphingomyelinase pathway) catalyzed by S1PR2 inhibits Akt while S1PR3 activates it;